BioMarin Pharmaceutical Inc (BMRN) Social Stream
BIOMARIN PHARMACEUTICAL INC (BMRN) Price Targets From Analysts
Use the tables below to see what analysts covering BIOMARIN PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 15 | $152 | $82 | $108.642 | $96 | 13.17% |
| 2021-11-15 | 15 | $152 | $82 | $108.928 | $96 | 13.47% |
| 2021-11-22 | 15 | $152 | $82 | $109.357 | $96 | 13.91% |
| 2022-01-05 | 15 | $155 | $88 | $111.5 | $96 | 16.15% |
| 2022-01-06 | 15 | $155 | $88 | $112.214 | $96 | 16.89% |
| 2022-01-21 | 14 | $155 | $88 | $112.571 | $96 | 17.26% |
| 2022-02-25 | 15 | $155 | $88 | $112.857 | $96 | 17.56% |
| 2022-02-28 | 15 | $155 | $88 | $115.75 | $96 | 20.57% |
| 2022-04-22 | 13 | $155 | $88 | $116.25 | $96 | 21.09% |
| 2022-04-26 | 13 | $155 | $88 | $117.666 | $96 | 22.57% |
| 2022-06-01 | 13 | $147 | $88 | $116.833 | $96 | 21.7% |
| 2022-06-21 | 13 | $136 | $70 | $110.416 | $96 | 15.02% |
| 2022-07-22 | 14 | $140 | $70 | $111.23 | $96 | 15.86% |
| 2022-08-02 | 13 | $140 | $70 | $113.166 | $96 | 17.88% |
| 2022-08-03 | 13 | $140.001 | $70 | $113.166 | $96 | 17.88% |
| 2022-08-05 | 14 | $140.001 | $70 | $114.769 | $96 | 19.55% |
| 2022-08-13 | 14 | $140.001 | $70 | $115 | $96 | 19.79% |
| 2022-09-27 | 14 | $140.001 | $74 | $115.384 | $96 | 20.19% |
| 2022-10-12 | 14 | $140.001 | $74 | $115.769 | $96 | 20.59% |
| 2022-10-21 | 15 | $140.001 | $74 | $113.857 | $96 | 18.6% |
| 2022-10-28 | 15 | $135 | $74 | $111.857 | $96 | 16.52% |
| 2022-11-23 | 15 | $135 | $74 | $113.142 | $96 | 17.86% |
| 2022-11-30 | 15 | $135 | $74 | $114.571 | $96 | 19.34% |
| 2023-01-04 | 15 | $135 | $74 | $115.285 | $96 | 20.09% |
| 2023-01-10 | 15 | $200 | $74 | $121.142 | $96 | 26.19% |
| 2023-01-13 | 15 | $200 | $83 | $121.785 | $96 | 26.86% |
| 2023-01-23 | 15 | $200 | $83 | $122.142 | $96 | 27.23% |
| 2023-01-27 | 15 | $200 | $83 | $123.5 | $96 | 28.65% |
| 2023-01-31 | 16 | $200 | $83 | $122.4 | $96 | 27.5% |
| 2023-02-08 | 16 | $200 | $83 | $122.933 | $96 | 28.06% |
| 2023-02-21 | 17 | $200 | $83 | $122.5 | $96 | 27.6% |
| 2023-02-27 | 17 | $200 | $83 | $123.333 | $96 | 28.47% |
| 2023-02-28 | 19 | $200 | $74 | $123.235 | $96 | 28.37% |
| 2023-03-07 | 19 | $200 | $74 | $123.176 | $96 | 28.31% |
| 2023-03-10 | 19 | $200 | $74 | $122.588 | $96 | 27.7% |
| 2023-04-24 | 20 | $200 | $74 | $120.277 | $96 | 25.29% |
| 2023-04-28 | 21 | $200 | $69 | $119.5 | $96 | 24.48% |
| 2023-06-12 | 21 | $200 | $69 | $119.315 | $96 | 24.29% |
| 2023-06-29 | 20 | $200 | $69 | $119.333 | $96 | 24.31% |
| 2023-06-30 | 20 | $200 | $73 | $119.555 | $96 | 24.54% |
| 2023-07-19 | 20 | $200 | $73 | $118.166 | $96 | 23.09% |
| 2023-08-01 | 20 | $185 | $73 | $117.333 | $96 | 22.22% |
| 2023-08-02 | 20 | $185 | $70 | $115.882 | $96 | 20.71% |
| 2023-08-23 | 20 | $185 | $70 | $115.882 | $96 | 20.71% |
| 2023-09-12 | 20 | $185 | $71 | $115.941 | $96 | 20.77% |
| 2023-09-14 | 20 | $185 | $78 | $116.352 | $96 | 21.2% |
| 2023-09-18 | 21 | $185 | $78 | $116.555 | $96 | 21.41% |
| 2023-10-16 | 22 | $185 | $78 | $116.555 | $96 | 21.41% |
| 2023-10-25 | 22 | $185 | $78 | $116.611 | $96 | 21.47% |
| 2023-11-01 | 23 | $185 | $78 | $116.315 | $96 | 21.16% |
| 2023-11-02 | 24 | $185 | $78 | $113.5 | $96 | 18.23% |
| 2023-11-07 | 24 | $170 | $78 | $112.15 | $96 | 16.82% |
| 2023-11-15 | 25 | $170 | $78 | $110.952 | $96 | 15.57% |
The Trend in the Analyst Price Target
Over the past 29 months, BMRN's average price target has gone up $3.84.
Over the past 44 weeks, BMRN's average upside potential has been 28.35%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-13 | 15 | 200 | 83 | 121.785 | 112.72 | 8.04% |
| 2023-06-12 | 21 | 200 | 69 | 119.315 | 93.32 | 27.86% |
| 2023-07-24 | 20 | 185 | 73 | 117.333 | 87.41 | 34.23% |
| 2023-08-23 | 19 | 185 | 70 | 115.882 | 91.07 | 27.24% |
| 2023-09-14 | 20 | 185 | 78 | 116.352 | 87.68 | 32.7% |
BMRN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 17 | 0 | 8 | 0 | 0 | 25 |
The Trend in the Broker Recommendations
BMRN's average broker recommendation rating worsened by 0.04 over the prior 35 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BMRN as an investment opportunity.
- In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 5461.78% of that group.
- In the context of Pharmaceutical Products stocks, BIOMARIN PHARMACEUTICAL INC's average analyst price target is higher than 5753.67% of them.
- In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -5147.89% of that group.
- In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1600.43% of that group.
Stocks similar to BIOMARIN PHARMACEUTICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NKTR, BHC, and VRTX.
View All Top Stocks by Price Target
Is BMRN a Buy, Hold or Sell? See the POWR Ratings now!